https://www.selleckchem.com/pr....oducts/aminoguanidin
A-induced GC cells. This study provided a theoretical basis in GC treatment with GA. Due to the low rate of regional recurrence (RR) in early-stage breast cancer with pT1-2 and negative sentinel lymph node biopsy (SLN, no regional therapy is suggested for them. However, whether there is a subset of patients who were with high risk of regional failure and may benefit from regional treatment is still unknown. The current study was designed to identify the patients with high risk of RR, thereby providing clues for en
Like
Comment
Share
